See People with medical risk factors for recommendations for Aboriginal and Torres Strait Islander people with condition(s) associated with an increased risk of invasive pneumococcal disease.

Current age (years)

1st dose of 23vPPV

2nd dose of 23vPPV
(1st revaccination)

3rd dose of 23vPPV
(2nd revaccination)

18 to <50 years

Not recommended

Not recommended

Not recommended

≥50 years

Give now

5 years after 1st dose

Not recommended

Last updated: 
5 June 2018
Last reviewed: 
5 June 2018

Definitions

23vPPV
23-valent pneumococcal polysaccharide vaccine